Adjusts IV fluid infusion in response to real-time urine output
Autonomous fluid balance management
Easy to set up and integrate into clinical practice
Validated technology in multiple studies and real-world settings
CE Approved for Fluid Management.
Core technology may be used for multiple clinical settings
The Console measures the volume of urine in the collection set and infuses an equal volume of hydration fluid, to match the patient’s urine output. It uses proprietary patented software and electronic weight measurements to control the fluid infusion rate and to monitor urine volume.
The proprietary disposable kits contain a urine collection set that connects to a patient’s Foley catheter and an infusion set that connects to a standard IV catheter.

Contrast agents are commonly used in cath lab procedures, but can be toxic to the kidneys. Several independent investigator-initiated studies and EU clinical trials have demonstrated the efficacy and safety of RenalGuard Therapy in reducing this risk and preventing CA-AKI.

AKI affects over 50% of ICU patients, driven by sepsis, infections, and nephrotoxic medications. CRS has initial clinical results that demonstrate the potential for reduction of ICU related AKI based on the clinical principles of fluid management for prevention of CSA-AKI and CA-AKI.
1.
Brown JR, BioMed Research
International. 2016:4278579.
2.
CDC Fast Stats: Death &
Mortality.2019.
3.
CMS
Announces Addition of Hospital Harm-AKI to Medicare’s Inpatient Quality
Reporting (IQR) program
4.
Hu et al. Global Incidence
& Outcomes of Adult Patients With AKI after Cardiac Surgery: A Systematic
Review & Meta-Analysis. Cardiothorac Vasc Anesth. 2016;30:82-9 > 320,000
patients. Lau D, et al. Costs & consequences of AKI after cardiac surgery:
A cohort study. J Thorac Cardiovasc Surg.
2021;162:880https://pubmed.ncbi.nlm.nih.gov/32299694/-887
5. Current standard of care is based on the KDIGO guidelines, which
suffer from poor compliance, due to complexity, and provide only minimal
reduction in AKI. (PrevAKI Study). Potential Reno-protective Strategies in
Cardiac Surgery. J Cardiothorac Vasc Anesth. (2021) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933995/.
6.
Heyman Luckraz et. al,
Reduction in acute kidney injury post cardiac surgery using balanced forced
diuresis: a randomized, controlled trial, European Journal of Cardio-Thoracic
Surgery, Volume 59, Issue 3, March 2021. https://academic.oup.com/ejcts/article/59/3/562/6000632